Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

ALDH1A (aldehyde dehydrogenase 1A), agonist and catalysate of ALDH1A, application of inhibitor

A technology for catalytic products and agonists, which can be used in the screening of compounds, active ingredients of heterocyclic compounds, biochemical equipment and methods, etc., and can solve problems that cannot be used to explain the mechanism of autism.

Active Publication Date: 2018-10-09
CENT FOR EXCELLENCE IN MOLECULAR CELL SCI CHINESE ACAD OF SCI
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Multiple substrates of the E3 ubiquitin ligase UBE3A have been reported, but still cannot be used to elucidate the mechanism of autism, so there may be other unknown substrate proteins that are dysfunctional in the brain of autistic patients (Sell et al., 2015)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • ALDH1A (aldehyde dehydrogenase 1A), agonist and catalysate of ALDH1A, application of inhibitor
  • ALDH1A (aldehyde dehydrogenase 1A), agonist and catalysate of ALDH1A, application of inhibitor
  • ALDH1A (aldehyde dehydrogenase 1A), agonist and catalysate of ALDH1A, application of inhibitor

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0147] 18. Virus Preparation and Brain-Targeted Injection

[0148] All indicated genes are driven by the Synapsin I (SynI) promoter and have a Flag tag fused to the N-terminus. The envelope protein serotype of adeno-associated virus (AAV) is AAV2 / 9, which is packaged by Shanghai Heyuan Biotechnology Company (Obio). AAV-SynI-Flag-UBE3A and AAV-SynI-Flag-UBE3A-T508E virus titers were approximately 1.5×10 13 Copy number / mL, AAV-SynI-Flag-EGFP virus titer is about 9.5×10 12 Copy number / mL.

[0149] 3-week-old mice were anesthetized by intraperitoneal injection of pentobarbital (50 mg / kg), and then fixed on a locator (Rivold, China). AAV virus diluted in 1 μL PBS was injected with a quantitative syringe pump (Stoelting) at a speed of 0.2 μL / min on both sides of the PFC area in the inner side of the mouse brain. Positions of targeted injections (relative to the bregma): AP, +2 mm; ML, ±0.5 mm; DV, -1.3 mm. The amount of virus injected at each injection point was: AAV-SynI-Flag-...

Embodiment 1

[0166] Example 1 The copy number amplification of chromosome 15q11.2-14 was found in the samples of autism patients

[0167] Three clinically diagnosed patients with autism phenotype were collected in the early stage, and the amplification of chromosome 15q11.2-14 ( figure 1 a-b). A series of genes are included in this expanded region, and their association with autism is not clear, except for the UBE3A gene which is generally confirmed to play a key role in the 15q expansion syndrome ( figure 1 b-c). The peripheral blood lymphocytes of these patients were established into immortalized cell lines by EBV virus infection method, so as to facilitate the follow-up functional research. Among them, compared with the control cells from healthy volunteers, the expression levels of UBE3A protein in these three autistic cells were significantly increased ( figure 1 d).

Embodiment 2

[0168] Example 2 Screening out the new substrate ALDH1A protein family of UBE3A

[0169] Since there is no known substrate of UBE3A that can explain the association between the pathogenesis of ASD and the overactivation of UBE3A from a mechanistic point of view (Glessner et al., 2009; Sell et al., 2015), the human UBE3A protein was first used as a bait, Unknown substrate proteins were screened by yeast two-hybrid method. Among them, many positive clones were found to carry the cDNA encoding the rate-limiting enzyme ALDH1A2 for RA synthesis ( figure 2 a). Retinoic acid RA, as an active metabolite of vitamin A (retinol), is required for the development and growth of higher animals including humans (Shearer et al., 2012). The synthesis of RA is completed by two steps, including retinol dehydrogenase (RDH10) that catalyzes retinol to retinal, and retinal dehydrogenase (ALDH1A1,2) that catalyzes retinal to retinoic acid. , 3 families). Co-immunoprecipitation experiments verifi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses ALDH1A (aldehyde dehydrogenase 1A), an agonist and a catalysate of the ALDH1A, and an application of an inhibitor. Particularly, the invention discloses the application of theALDH1A or the agonist or the catalysate, the ALDH1A is used to prepare a pharmaceutical composition or preparation, and the pharmaceutical composition or preparation is used to treat and / or prevent infantile autism.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular, the invention relates to the use of ALDH1A and its agonists, catalytic products and inhibitors. Background technique [0002] Autism spectrum disorder, referred to as "autism", also known as "autism", its core symptoms are social communication and communication barriers, repetitive stereotyped behavior, is a serious neurodevelopmental disorder. Among them, in autism cases, chromosome 15q11-q13 copy number amplification (CNV) accounts for 1-3%; this CNV can cause excessive activation of UBE3A E3 ubiquitin ligase, but its specific pathogenic mechanism is not clear . [0003] Autism spectrum disorder is a generalized neurodevelopmental disorder with diverse etiologies, and its core symptoms are mainly reflected in deficits in social interaction and communication skills, and limited repetitive interests, behaviors or activities (Huguet et al. , 2013; Zoghbi et al., 2012). So far, the ge...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/203A61K45/00A61K31/4174A61K31/47A61P25/00C12Q1/66C12Q1/32G01N21/64
CPCA61K45/00G01N21/6486A61K31/203A61K31/4174A61K31/47C12Q1/32C12Q1/66G01N2800/30A61K2300/00A61K31/07A61K31/11A61K31/192A61K31/4436A61K31/44A61K31/343A61K31/496A61K31/4402A61K45/06A61P25/00G01N2500/00Y02A50/30A61K31/357A61K31/4164A61K31/4184A61K31/428A61K38/44
Inventor 胡荣贵徐星星高晓博李传银郝子健
Owner CENT FOR EXCELLENCE IN MOLECULAR CELL SCI CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com